Separation of fibrinogen from plasma proteases
AssigneeCSL Limited
InventorsJerry Kanellos, Michael Kleinig, Teresa Martinelli
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for purifying fibrinogen. In one aspect, the present invention relates to a method of separating fibrinogen from plasma fraction I precipitate. In another aspect, the invention relates to the purification of fibrinogen using ion exchange chromatography.
Claims45
A method for purifying fibrinogen, the method comprising extracting fibrinogen from a Fraction I precipitate by admixing the Fraction I precipitate with an extraction buffer such that fibrinogen is solubilised in the extraction buffer, wherein the extraction buffer comprises salt at a concentration of at least 0.1M and heparin at a concentration of at least 10 IU/ml.
A method of purifying fibrinogen, the method comprising:
- (a) extracting fibrinogen from a Fraction I precipitate by admixing the Fraction I precipitate with an extraction buffer such that fibrinogen is solubilised in the extraction buffer, wherein the extraction buffer comprises salt at a concentration of at least 0.1M;
- (b) precipitating the fibrinogen;
- and
- (c) solubilising the fibrinogen in a solution comprising at least one ω-amino acid at a concentration of at least 100 mM.
A method for purifying fibrinogen, which method comprises:
- (a) extracting fibrinogen from a fibrinogen containing material by admixing the material with an extraction buffer such that fibrinogen is solubilised in the extraction buffer, wherein the extraction buffer comprises at least one ω-amino acid at a concentration of at least 5 mM;
- (b) applying the extraction buffer from step (a) to an ion exchange matrix under conditions such that fibrinogen binds to the matrix;
- (c) eluting the fibrinogen from the matrix;
- and
- (d) optionally recovering the fibrinogen from the eluate.
A method of purifying fibrinogen from a fibrinogen containing solution, the method comprising:
- (a) applying the solution to an ion exchange matrix, under conditions such that fibrinogen binds to the matrix;
- (b) washing the ion exchange matrix with a solution comprising at least one ω-amino acid;
- (c) eluting the fibrinogen from the matrix;
- and
- (d) optionally recovering the fibrinogen from the eluate.
Dependencies are inferred from the claim text.